Cargando…

Immune Correlates of Natural HIV Elite Control and Simultaneous HCV Clearance—Supercontrollers

HIV-elite controllers are a minority group of HIV-infected patients with the ability to maintain undetectable HIV viremia for long time periods without antiretroviral treatment. A small group of HIV-controllers are also able to spontaneously clear the hepatitis C virus (HCV) whom we can refer to as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dominguez-Molina, Beatriz, Ferrando-Martinez, Sara, Tarancon-Diez, Laura, Hernandez-Quero, Jose, Genebat, Miguel, Vidal, Francisco, Muñoz-Fernandez, Mª Angeles, Leal, Manuel, Koup, Richard, Ruiz-Mateos, Ezequiel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295470/ https://www.ncbi.nlm.nih.gov/pubmed/30619267 http://dx.doi.org/10.3389/fimmu.2018.02897

Ejemplares similares

Long-term Persistent Elite HIV-controllers: The Right Model of Functional Cure
por: Tarancon-Diez, Laura, et al.
Publicado: (2018)

Persistent HIV‐controllers are more prone to spontaneously clear HCV: a retrospective cohort study
por: Dominguez‐Molina, Beatriz, et al.
Publicado: (2020)

Coronavirus Disease (COVID-19): A Perspective from Immunosenescence
por: Genebat, Miguel, et al.
Publicado: (2021)

Polyfunctional HIV-1 specific response by CD8+ T lymphocytes expressing high levels of CD300a
por: Vitallé, Joana, et al.
Publicado: (2020)

Immunometabolism is a key factor for the persistent spontaneous elite control of HIV-1 infection
por: Tarancon-Diez, Laura, et al.
Publicado: (2019)

Altered Expression of CD300a Inhibitory Receptor on CD4+ T Cells From Human Immunodeficiency Virus-1-Infected Patients: Association With Disease Progression Markers
por: Vitallé, Joana, et al.
Publicado: (2018)

Threshold Ferritin Concentrations Reflecting Early Iron Deficiency Based on Hepcidin and Soluble Transferrin Receptor Serum Levels in Patients with Absolute Iron Deficiency
por: Tarancon-Diez, Laura, et al.
Publicado: (2022)

Short-term maraviroc exposure, a clinical approach to decide on maraviroc prescription in HIV-1-infected treatment-naïve patients
por: Gonzalez-Serna, Alejandro, et al.
Publicado: (2016)

Improved CD4 T cell profile in HIV-infected subjects on maraviroc-containing therapy is associated with better responsiveness to HBV vaccination
por: Herrero-Fernández, Inés, et al.
Publicado: (2018)

Increased CD127+ and decreased CD57+ T cell expression levels in HIV-infected patients on NRTI-sparing regimens
por: Gonzalez-Serna, A., et al.
Publicado: (2017)

Persistent Exhausted T-Cell Immunity after Severe COVID-19: 6-Month Evaluation in a Prospective Observational Study
por: Vazquez-Alejo, Elena, et al.
Publicado: (2023)

The use of alpha 1 thymosin as an immunomodulator of the response against SARS-Cov2
por: Espinar-Buitrago, M. S., et al.
Publicado: (2023)

Antiretroviral Treatment for HIV Elite Controllers?
por: Ruiz-Mateos, Ezequiel, et al.
Publicado: (2020)

Identification of the transcripts associated with spontaneous HCV clearance in individuals co-infected with HIV and HCV
por: Chen, Yue, et al.
Publicado: (2016)

Permanent control of HIV-1 pathogenesis in exceptional elite controllers: a model of spontaneous cure
por: Casado, Concepcion, et al.
Publicado: (2020)

Reduced sTWEAK and Increased sCD163 Levels in HIV-Infected Patients: Modulation by Antiretroviral Treatment, HIV Replication and HCV Co-Infection
por: Beltrán, Luis M., et al.
Publicado: (2014)

Spontaneous Clearance of Chronic HCV: The Key Ending Left in the Dark
por: Mumdzhiev, Nikola Hristov, et al.
Publicado: (2019)

Silent damage? Occult HCV replication and histological disease may occur following apparent HCV clearance
por: Manickam, Cordelia, et al.
Publicado: (2019)

SARS-CoV-2 in patients on antiviral HBV and HCV therapy in Spain
por: Lens, Sabela, et al.
Publicado: (2020)

Reversal of Immunity After Clearance of Chronic HCV Infection—All Reset?
por: Wedemeyer, Heiner, et al.
Publicado: (2020)

Identity by descent mapping of HCV spontaneous clearance in populations of diverse ancestry
por: Yu, Zixuan, et al.
Publicado: (2023)

Occult HCV or delayed viral clearance from lymphocytes of Chronic HCV genotype 3 patients after interferon therapy
por: Muazzam, Ambreen G, et al.
Publicado: (2011)

HTLV-1 infection modulates the immune response in HIV-HCV coinfected patients and may increase spontaneous HCV clearance
por: Bahia, Fabianna, et al.
Publicado: (2014)

Role of APOBEC3H in the Viral Control of HIV Elite Controller Patients
por: Benito, José M., et al.
Publicado: (2018)

Telomere Length Increase in HIV/HCV-Coinfected Patients with Cirrhosis after HCV Eradication with Direct-Acting Antivirals (†)
por: Molina-Carrión, Silvia, et al.
Publicado: (2020)

Evaluation of the degree of liver fibrosis and genetical characteristics in HIV patients with spontaneous clearance of HCV in Cartagena, Spain
por: Jesús Vera Méndez, Francisco, et al.
Publicado: (2014)

Fibrosis Evaluation by Transient Elastography in Patients With Long-Term Sustained HCV Clearance
por: Calvaruso, Vincenza, et al.
Publicado: (2013)

Enhanced host immune responses in presence of HCV facilitate HBV clearance in coinfection
por: Liu, Shuhui, et al.
Publicado: (2022)

HIV-Infected Subjects With Poor CD4 T-Cell Recovery Despite Effective Therapy Express High Levels of OX40 and α4β7 on CD4 T-Cells Prior Therapy Initiation
por: Rosado-Sánchez, Isaac, et al.
Publicado: (2018)

Interleukin 18 (IL-18) and IL-3 in Extracellular Vesicles: Biomarkers for Durable Elite Control of HIV-1
por: Poveda, Eva, et al.
Publicado: (2023)

Natural Killer KIR3DS1 Is Closely Associated with HCV Viral Clearance and Sustained Virological Response in HIV/HCV Patients
por: Rivero-Juarez, Antonio, et al.
Publicado: (2013)

Relationship of TRIM5 and TRIM22 polymorphisms with liver disease and HCV clearance after antiviral therapy in HIV/HCV coinfected patients
por: Medrano, Luz M., et al.
Publicado: (2016)

Dynamics of HIV Reservoir and HIV-1 Viral Splicing in HCV-Exposed Individuals after Elimination with DAAs or Spontaneous Clearance
por: Martínez-Román, Paula, et al.
Publicado: (2022)

Clearance of low levels of HCV viremia in the absence of a strong adaptive immune response
por: Meyer, Manuela F, et al.
Publicado: (2007)

Genetic variants in interferon-λ 4 influences HCV clearance in Chinese Han population
por: Huang, Peng, et al.
Publicado: (2017)

Development of Immature CD4(+)CD8(+)T Cells Into Mature CD4(+) T Cells Requires Alpha-1 Antitrypsin as Observed by Treatment in HIV-1 Infected and Uninfected Controls
por: Bristow, Cynthia L., et al.
Publicado: (2019)

Single Clinical Practice's Report of Testing Initiation, Antibody Clearance, and Transmission of Hepatitis C Virus (HCV) in Infants of Chronically HCV-Infected Mothers
por: Bal, Aswine, et al.
Publicado: (2016)

Evolution of Serum Acute-Phase Glycoproteins Assessed by (1)H-NMR in HIV Elite Controllers
por: Malo, Ana-Irene, et al.
Publicado: (2021)

Genetic variants in RIG-I-like receptor influences HCV clearance in Chinese Han population
por: Wu, Xinyu, et al.
Publicado: (2019)

2510. Adapting the CDC HCV viral clearance cascade methodology for persons with HIV (PWH) and HCV co-infection in 5 Health Department Jurisdictions in the US
por: Wegener, Maximilian D, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0d0qr1srel1ak0r4g7jpnqvmjf